INSIGHTS ON DRUG DEVELOPMENT

• The Simplest, Most Powerful Digital PCR Workflow Family

  Scalable digital PCR provides high-throughput automation for up to 384 samples. Support seven-color multiplexing and 3D data analysis to achieve superior sensitivity and streamlined laboratory workflows.

• How Organ-Chips Are Transforming Women's Reproductive Health Research

  Traditional models often fall short in women’s health research. Learn how human-relevant Organ-Chip systems are providing new ways to study vaginal, cervical, and uterine biology.

• Corticosteroids And Hormonal Therapies — History, Use, And Future Outlook

  Explore how evolving science, expanding global demand, and next-generation innovations are reshaping the future of corticosteroid and hormonal therapies — and what this transformation means for the years ahead.

• Building Oral Dosage Forms for Speed Today And Success Tomorrow

  Move toward the clinic with confidence using integrated development strategies that support smarter decisions and more efficient product development.

   

• Streamlining Early Drug Development: Efficient Synthesis Of Highly Potent Compounds

  5/6/2026

  Discover how risk‑based, phase‑appropriate synthesis enables safe, efficient production of highly potent compounds while balancing speed, worker safety, and regulatory readiness in early development.

• Enhancing Throughput And Reproducibility In Proteomic Analysis

  8/27/2025

  Streamline proteomic workflows with consistent sample preparation. Discover how simplifying LC-MS processes can eliminate bottlenecks, improve reproducibility, and accelerate drug discovery research.

• Lipid Formulations In Softgels: Enhancing Bioavailability And Therapeutic Efficacy

  8/31/2026

  Discover how lipid-based softgel formulations can enhance drug absorption, improve bioavailability, and advance drug delivery across a range of therapeutic applications.

• mTOR Pathway

  3/24/2025

  Explore the mTOR signaling pathway and reveal how mTORC1 regulates cell growth, metabolism, and survival to ensure cellular function and adaptation to environmental cues.

• Why CDMO Performance Drops Exactly When It Matters Most

  6/15/2026

  Programs often stall moving to GMP due to fragmented workflows and knowledge gaps. Aligning teams and integrating development with execution, via continuous data, sustains momentum and reduces risk.